Genomic surveillance reveals dynamic shifts in the connectivity of COVID-19 epidemics
Summary
The maturation of genomic surveillance in the past decade has enabled tracking of the emergence and spread of epidemics at an unprecedented level. During the COVID-19 pandemic, for example, genomic data revealed that local epidemics varied considerably in the frequency of SARS-CoV-2 lineage importation and persistence, likely due to a combination of COVID-19 restrictions and changing connectivity. Here, we show that local COVID-19 epidemics are driven by regional transmission, including across international boundaries, but can become increasingly connected to distant locations following the relaxation of public health interventions. By integrating genomic, mobility, and epidemiological data, we find abundant transmission occurring between both adjacent and distant locations, supported by dynamic mobility patterns. We find that changing connectivity significantly influences local COVID-19 incidence. Our findings demonstrate a complex meaning of ‘local’ when investigating connected epidemics and emphasize the importance of collaborative interventions for pandemic prevention and mitigation.
Competing Interest Statement
K.G.A. has received consulting fees and compensated expert testimony on SARS-CoV-2 and the COVID-19 pandemic.
Funding Statement
The research leading to these results has received funding from the National Institutes of Health (grants U19AI135995, U01AI151812, UL1TR002550, F32AI154824, and R01AI153044) and the CDC contract 7530122C14843. We also gratefully acknowledge support from NVIDIA Corporation and Advanced Micro Devices, Inc., with the donation of parallel computing resources used for this research.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Sample collection, RNA extraction, and viral sequencing was evaluated by the Institutional Review Board (IRB) at Scripps Health (IRB-21-7739). All samples were de-identified before receipt by the study investigators. Aggregated contact tracing data was publicly available prior to the initiation of the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The data that support the findings of this study are openly available in Github at https://github.com/andersen-lab/project_2023_SARS-CoV-2_Connectivity
https://github.com/andersen-lab/project_2023_SARS-CoV-2_Connectivity
Subject Area
- Addiction Medicine (381)
- Allergy and Immunology (697)
- Anesthesia (187)
- Cardiovascular Medicine (2827)
- Dermatology (242)
- Emergency Medicine (427)
- Epidemiology (12527)
- Forensic Medicine (10)
- Gastroenterology (799)
- Genetic and Genomic Medicine (4407)
- Geriatric Medicine (399)
- Health Economics (712)
- Health Informatics (2836)
- Health Policy (1044)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (412)
- Medical Ethics (114)
- Nephrology (460)
- Neurology (4161)
- Nursing (220)
- Nutrition (615)
- Oncology (2191)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (316)
- Pain Medicine (264)
- Palliative Medicine (81)
- Pathology (484)
- Pediatrics (1169)
- Primary Care Research (481)
- Public and Global Health (6744)
- Radiology and Imaging (1483)
- Respiratory Medicine (896)
- Rheumatology (429)
- Sports Medicine (362)
- Surgery (471)
- Toxicology (57)
- Transplantation (198)
- Urology (173)